Taiwan's medical device company challenges the limit of science, launching the most expensive collagen in the contemporary market
Retrieved on:
Friday, August 6, 2021
As a leading global medical device brand, Maxigen Biotech Inc. (MBI),a subsidiary of TCI Co., Ltd.,has been focused on developing medical standard collagen dressings and regenerative matrix, providing diverse products for postoperative patients.
Key Points:
- As a leading global medical device brand, Maxigen Biotech Inc. (MBI),a subsidiary of TCI Co., Ltd.,has been focused on developing medical standard collagen dressings and regenerative matrix, providing diverse products for postoperative patients.
- Now MBI crosses over to put effort on collagen food product, using double enzyme hydrolysis to build the most concentrated tripeptide MAXI Collagen.
- More than 90% of the collagen in the human body is Type I Collagen, and the main collagen component of cartilage is Type II Collagen.
- Consumers can experience the natural beauty from the most premium and expensive collagen in just 7 days.